Analyst Profile

Followed by 214 followers
.
Raju Prasad

Raju Prasad

William Blair
Wall Street Analyst
#7,612 out of 8,164 Wall Street Analysts
#22,892 out of 24,495 experts

Success Rate

38%
145 out of 383 transactions made a profit

Average Return

-4.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Raju Prasad's trades since 2018 and holding each position for 1 Year would result in 37.86% of your transactions generating a profit, with an average return of -4.7% per rating.

Stock Rating Distribution

640Ratings
84.22% Buy
15.78% Hold
0.00% Sell
Distribution of Raju Prasad's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Logicbio Therapeutics
(LOGC)
Rating:Buy
Date:Aug 16, 2022 - Oct 03, 2022
Return:+378.50%
The most profitable rating made by Raju Prasad

Raju Prasad's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
BIVV
Bioverativ Inc
Mar 08, 2018
Hold
Reiterated
1Ratings
0.00%
AVXS
AveXis Inc
May 16, 2018
Hold
Reiterated
10Ratings
0.00%
LOXO
Loxo Oncology
Feb 15, 2019
Hold
Reiterated
14Ratings
100%
+31.80%
ONCE
Spark Therapeutics
Dec 17, 2019
Hold
Reiterated
15Ratings
100%
+110.40%
BOLD
Audentes Therapeutics
Jan 15, 2020
Hold
Reiterated
17Ratings
0%
-16.45%
ALXN
Alexion Pharmaceuticals
Jul 21, 2021
Hold
Reiterated
18Ratings
60%
+1.94%
Assembly Biosciences
Nov 26, 2021
Hold
Reiterated
26Ratings
25%
-26.10%
Poseida Therapeutics
May 13, 2022
Buy
Reiterated
19Ratings
14%
-29.36%
Taysha Gene Therapies
May 16, 2022
Buy
Reiterated
16Ratings
0%
-77.93%
PTC Therapeutics
Aug 04, 2022
Buy
Reiterated
54Ratings
54%
+3.69%
List of latest recommendations made by Raju Prasad. Click to expand and see Raju Prasad's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >